One-Alpha is indicated for the treatment of rickets and osteomalacia resulting from malnutrition and malabsorption, rickets and osteomalacia resulting from vitamin D deficiency, and all conditions in which calcium metabolism is disturbed due to impairment of the 1-α hydroxylation process, such as decreased renal function. The main indications for
One-Alpha are the treatment of glomerular osteoblastic dysplasia, hyperparathyroidism associated with bone disease, hypoparathyroidism, and hypocalcemia in newborns.